For its first fiscal quarter (ending March 31), Veracyte Inc (NASDAQ: VCYT) has reported E.P.S. of $-0.02 compared to $-0.11 a year ago. This performance was $-0.01 short of the consensus estimate of $-0.01. E.P.S. were $-0.94 for the latest four quarters through March 31 versus $-0.41 for the same period a year ago.
Recent Price Action
On 5/7/24, Veracyte Inc (NASDAQ: VCYT) stock rose modestly by 0.5%, closing at $21.03. NORMAL trading volume accompanied the advance. Relative to the market the stock has been weak over the last nine months but has risen 3.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be below the cost of capital, VCYT is expected to continue to be a modest Value Eraser.
Veracyte has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Veracyte has a slightly negative Appreciation Score of 32 and a very low Power Rating of 7, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment